REGENXBIO Inc. (RGNX)Stock price, Description, News & Info

#Thinksabio latest news

REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II